Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Theravance Biopharma (TBPH) Change in Acquisitions & Divestments (2016 - 2025)

Theravance Biopharma (TBPH) has disclosed Change in Acquisitions & Divestments for 13 consecutive years, with $65.5 million as the latest value for Q4 2025.

  • Quarterly Change in Acquisitions & Divestments rose 63.6% to $65.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $143.0 million through Dec 2025, up 2.26% year-over-year, with the annual reading at $143.0 million for FY2025, 2.26% up from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $65.5 million at Theravance Biopharma, up from $24.5 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $115.5 million in Q1 2021, with the low at -$91.7 million in Q3 2022.
  • Average Change in Acquisitions & Divestments over 5 years is $30.0 million, with a median of $36.3 million recorded in 2023.
  • The sharpest move saw Change in Acquisitions & Divestments crashed 332950.0% in 2023, then surged 200.27% in 2024.
  • Over 5 years, Change in Acquisitions & Divestments stood at $64.8 million in 2021, then crashed by 99.98% to $12000.0 in 2022, then plummeted by 332950.0% to -$39.9 million in 2023, then soared by 200.27% to $40.1 million in 2024, then soared by 63.6% to $65.5 million in 2025.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $65.5 million, $24.5 million, and $20.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.